ABEO
Abeona Therapeutics Inc.
NASDAQ · USHealthcareBiotechnology
$6.48-7.43%
Price as of Jul 20, 2026
ABEO capital
Abeona Therapeutics Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.16x
- Net debt / equity
- -0.26x
- Debt / assets
- 0.12x
- Debt / EBITDA
- 0.32x
- Net debt / EBITDA
- -0.52x
Liquidity & coverage
- Current ratio
- 5.89x
- Quick ratio
- 5.70x
- Cash ratio
- 5.42x
- Interest coverage
- -25.97x
- EBITDA / interest
- 20.56x
- Working capital
- $151.9M
Cash & dividend
- FCF / debt
- -3.68x
- Cash flow / debt
- -3.35x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.